Culture influences your choices about money. This applies in normal life, but also in the business of biotech funding and if you want to build an international business, or invest…
In the current trade standoff between the US and China, Europe has a golden opportunity to gain a competitive advantage. At every healthcare conference I’ve been to recently in the…
From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the oft-repeated saying, “may you live in interesting times,” is a blessing or a curse depends…
The key for a European biotech is to find the money where it is. And that’s not in Europe for the moment. Going public is obviously a necessary evil for…